STOCK TITAN

Institutional 13G/A: Divisadero Holds 7.5%–8.4% of AngioDynamics

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Divisadero Street Capital and related entities report ownership of material stakes in AngioDynamics common stock. The filing shows Divisadero Street Capital Management, LP and affiliated entities report beneficial ownership of 3,395,430 shares, representing 8.4% of the class, while Divisadero Street Partners, L.P. and its GP report 3,054,469 shares (approximately 7.5%). The reported positions are held with shared voting and dispositive power only; no reporting person asserts sole voting or sole dispositive power.

The filing states that all reported securities are directly owned by advisory clients of Divisadero Street Capital Management, LP and that each reporting person disclaims beneficial ownership except to the extent of any pecuniary interest. The filing includes a joint filing agreement and a control-person identification exhibit.

Positive

  • Filing discloses a material institutional stake: 3,395,430 shares representing 8.4% of AngioDynamics common stock.
  • Document states that all reported securities are directly owned by advisory clients of Divisadero Street Capital Management, LP, clarifying ownership source.

Negative

  • Reporting persons assert no sole voting or sole dispositive power; all voting and dispositive power is reported as shared.
  • Each reporting person disclaims beneficial ownership

Insights

TL;DR Passive institutional disclosure: a meaningful >5% stake reported, no sole control.

This Schedule 13G/A discloses a material passive position in AngioDynamics by Divisadero Street affiliates totaling 3,395,430 shares (8.4%), with Divisadero Street Partners holding 3,054,469 shares (7.5%). The filing is consistent with a passive investor posture: voting and dispositive powers are shared and the reporting persons disclaim beneficial ownership except for pecuniary interest. For investors, this is a notable ownership disclosure but not an active control signal given the 13G treatment and the explicit shared-power assertions.

TL;DR Material position disclosed but governance influence appears limited by shared power and disclaimers.

The report documents sizable holdings by advisory clients of Divisadero Street entities and shows no sole voting or dispositive authority claimed by the reporting persons. The disclaimer of beneficial ownership except for pecuniary interest and the use of a Schedule 13G/A indicate a passive investment intent rather than a change-in-control campaign. The inclusion of a joint filing agreement and control-person identification provides standard governance transparency for institutional filings.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Divisadero Street Capital Management, LP
Signature:By: Divisadero Street Capital LLC, its general partner , By: /s/ William Zolezzi
Name/Title:William Zolezzi/Manager
Date:08/13/2025
William Zolezzi
Signature:/s/ William Zolezzi
Name/Title:William Zolezzi
Date:08/13/2025
Divisadero Street Partners, L.P.
Signature:By: Divisadero Street Partners GP, LLC, its general partner, By: /s/ William Zolezzi
Name/Title:William Zolezzi/Manager
Date:08/13/2025
Divisadero Street Partners GP, LLC
Signature:/s/ William Zolezzi
Name/Title:William Zolezzi/Manager
Date:08/13/2025
Divisadero Street Capital, LLC
Signature:/s/ William Zolezzi
Name/Title:William Zolezzi/Manager
Date:08/13/2025

Comments accompanying signature: * Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. To the extent that "ownership of 5 percent or less of a class" was indicated in Item 5, such response only applies to the Reporting Person(s) that indicated elsewhere herein that it beneficially owns five percent (5%) or less of the class.
Exhibit Information

Exhibit A - Joint Filing Agreement Exhibit B - Control Person Identification

FAQ

How many AngioDynamics (ANGO) shares does Divisadero Street report owning?

The filing reports 3,395,430 shares beneficially owned by Divisadero Street Capital affiliates.

What percentage of ANGO does that stake represent?

The reported position represents 8.4% of AngioDynamics' common stock for Divisadero Street Capital Management, LP.

Does the filer claim sole voting or dispositive power over these shares?

No. The filing states 0 sole voting power and 0 sole dispositive power; all voting and dispositive power is shared.

Are the shares directly owned by the filing entities or by their clients?

The filing states that all securities reported are directly owned by advisory clients of Divisadero Street Capital Management, LP.

What type of SEC filing is this for ANGO?

This is a Schedule 13G/A filing disclosing beneficial ownership by institutional/qualified investors.

Who signed the filing on behalf of the reporting persons?

The filing was signed by William Zolezzi on behalf of the Divisadero Street reporting entities.